Biodesix (BDSX) 10% Owner Jack W. Schuler Buys Stock

What Happened
Jack W. Schuler, reported as a 10% owner of Biodesix, purchased 15,000 shares of BDSX on August 12, 2026. The filing reports a weighted-average purchase price of $24.47 per share, for a total reported outlay of $366,992. This was an open-market purchase (code P), which is a direct buy of company stock.

Key Details

• Transaction date: 2026-08-12; Form filed: 2026-08-13 (timely filing).
• Price reported: weighted average $24.47; actual trade prices ranged from $24.00 to $24.50 (footnote F1).
• Shares acquired: 15,000; total value reported: $366,992.
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: F1 clarifies the weighted-average price and availability of per-price breakdown on request; F2 and F3 note Schuler is sole trustee of the Jack W. Schuler Living Trust and the Jack W. Schuler 2026 GRAT, indicating the trusts' involvement in his beneficial ownership.
• No indication this was a derivative transaction, gift, or exercise—this was an open-market purchase by a 10% owner.

Context
Purchases by large shareholders (10% owners) can signal confidence but are simply factual data points rather than proof of future performance. The filing is timely and straightforward: multiple small trades aggregated into a single reported purchase with a disclosed price range. If you want more granular pricing per trade, the filing states the reporting person will provide that detail to the company, shareholders, or the SEC staff upon request.